Skip to main content

Table 2 Demographic data of patients on VA-ECMO

From: Acute neurological complications in adult patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation support

Studied parametersAll patients (67), N (%)CNS events (38), N (%)No CNS events (29), N (%)p valueIschaemic stroke (n = 10), N (%)ICH (n = 8), N (%)p value
Age (years)40.13 ± 14.240.84 ± 15.939.21 ± 11.670.03244.9 ± 15.132.25 ± 11.80.01
SexMales49 (73.2)28 (73.7)21 (72.4)0.565 (50)5 (62.5)0.32
Females18 (26.8)10 (26.3)8 (27.6)5 (50)3 (37.5)
BMI25.97 ± 7.2525 ± 7.2327.24 ± 7.210.6528.30 ± 7.221.38 ± 4.80.03
Diabetes mellitus12 (17.9)7 (18.4)5 (17.2)0.834 (40)00.02
Systemic hypertension19 (28.4)12 (31.6)7 (24.1)0.594 (40)1 (12.5)0.07
Chronic kidney disease14 (20.9)11 (28.)3 (10.3)0.083 (30)2 (25)0.52
History of stroke3 (4.47)3 (7.9)00.1702 (25)0.16
History of epilepsy1 (1.49)1 (2.63)00.2901 (12.5)0.24
Left ventricle EF33.63 ± 13.84 %33.76 ± 13.2933.45 ± 14.760.1737.40 ± 13.836.75 ± 16.10.19
Pre-ECMO AF25 (37.3)15 (39.5)10 (34.5)0.82 (20)5 (62.5)0.04
History of oral anticoagulants27 (40.3%)15 (39.5)12 (41.4)0.563 (30)4 (50)0.07
Cardiothoracic surgery44 (65.7%)28 (73.6)16 (55.2)0.126 (60)7 (87.5)0.04
Cardiopulmonary bypass time (minutes)229.9 ± 97.1245.1 ± 105.6203.1 ± 75.750.16180.40 ± 117.13250.5 ± 89.70.01
Aortic clamping time (minutes)149.53 ± 56.46154.75 ± 58.57139.08 ± 52.840.42129.00 ± 80.72173.4 ± 53.60.03
IABP13 (19.4)9 (23.7)4 (15.4)0.244 (40)1 (12.5)0.03
SOFA score at admission13.10 ± 3.5214.34 ± 2.9511.48 ± 3.590.00113.00 ± 3.4915.25 ± 1.80.001
SOFA score after 48 hours14.61 ± 5.8216.82 ± 4.9311.72 ± 5.730.00115.20 ± 5.6918.25 ± 4.10.001
Type of ECMOCentral35 (52.2)22 (57.9)13 (44.8)0.335 (50)6 (75)0.04
Peripheral32 (47.8)16 (42.1)16 (55.2)5 (50)2 (25)
Days before event10.21 ± 5.79.40 ± 5.1911.13 ± 7.10.21
AF during ECMO36 (53.7)26 (68.4)10 (34.5)0.0078 (80)5 (62.5)0.03
Intracardiac thrombi6 (8.9)5 (13.2)1 (3.4)0.24 (40)00.04
ECMO circuit thrombi4 (5.9)3 (7.9)1 (3.4)0.41 (10)00.6